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responsibility of InAbstract Previous studies have demonstrated the important role of angiotension II (AngII) in
promoting proliferation of myoﬁbroblasts (myoFbs) and myocardial ﬁbrosis. However, the
underlying mechanisms and the role of oxygen free radicals in the proliferation of myoﬁbroblasts
induced by AngII are unclear. The present study was designed to shed light on this issue through
exploration of AngII signaling pathways via in vitro experiments. Primary cultures of neonatal rat
myoFbs were divided into ﬁve groups which were treated with AngII (108 to 106 M), AngII with
the antioxidant N-acetyl-L-cysteine (NAC), or normal culture medium. We observed the
proliferation of myoFbs as induced by AngII at different concentrations with MTT. Reactive
oxygen species (ROS) levels in myoFbs were detected by monitoring the ﬂuorescence of
20,70-dichloroﬂuorescein. The contents and levels of oxygen free radicals (OHd) in the three groups
were detected by spectrophotometer, immunocytochemical staining, and confocal ﬂuorescence.
Western blot and image analysis were used to measure membrane translocation and expression of
phospho-protein kinase Ca. MyoFbs incubated with AngII (108 to 106 M) for 24 h increased
their rate of proliferation, the content of OHd, and expression of ROS (Po0.01 vs. control group),
whereas these parameters decreased in the presence of NAC. Immunocytochemistry, confocal
ﬂuorescence staining and image analysis showed that AngII could promote the translocation and
expression of p-PKCa in membrane, and the antioxidant NAC blocked this increase (Po0.01).
Western blot results also showed that NAC could inhibit the expression of p-PKCa.
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Role of oxygen free radicals in the proliferation of myoﬁbroblasts induced by AngII 331. Introduction
Myocardial ﬁbrosis is seen in several pathological conditions,
such as hypertension, myocardial infarction and heart failure1.
In a normal heart, myocardial cells and myoﬁbroblasts
(myoFbs) are the major components of heart tissue. In disease
conditions abnormal proliferation of myoFbs can increase the
accumulation of interstitial collagens and lead to myocardial
ﬁbrosis, resulting in myocardial stiffness that ultimately dis-
rupts the coordination of myocardial excitation-contraction
coupling in both diastole and systole1–5.
Protein kinase C (PKC) is a group of closely related serine–
threonine protein kinases expressed in all tissues. Members of
the PKC family are important signal transducers in virtually
every mammalian cell type. In the heart, PKC isozymes were
thought to participate in a signal network that programs
developmental and pathological myoFbs proliferation. The
mRNA expression of PKCs is found in cultured rat cardio-
myocytes. PKC isozymes are involved in a variety of chronic
cardiac diseases as well as in acute cardiac injuries and
preconditioning cytoprotection. Interference with such signal
pathways may result in inhibition of myoFbs proliferation,
myocardial ﬁbrosis and reverse cardiac remodeling.
Much research has shown that the stress produced by oxygen
radicals on cardiovascular cell toxicity is an important compo-
nent of many cardiovascular diseases6,7. However, the recent
literatures reported that free radicals generated during oxidative
stress may act as intracellular signal transduction molecules and
are involved in the regulation of cell function8,9. In this study,
oxidative stress of myoFbs was induced by angiotensin II
(AngII), and the ability of N-acetylcysteine (NAC) to prevent
this proliferation was determined. Our results demonstrate that
NAC can inhibit the proliferation of myoFbs induced by
AngII, perhaps by decreasing the content of oxygen free
radicals (OHd) and inhibition of the membrane translocation
and expression of p-PKCa. Identiﬁcation of the signaling
pathways involved in myocardial remodeling in response to
AngII may reveal new therapeutic targets in the prevention and
treatment of cardiovascular diseases.2. Materials and methods
2.1. Materials
Wistar rats of 1–3 days old were purchased from the Center of
Experimental Animals of Jilin University (Certiﬁcate No. of
animals was SCXK (JI) 2007-0003). AngII and anti-b-actin
were from Sigma Chemicals (St. Louis, USA). PKCa antibody
(anti-PKCa goat polyclonal antibody) was from Santa Cruz
Biotechnology (Santa Cruz, CA). Goat secondary antibodies
with ﬂuorescein isothiocyanate (FITC) were from BOSTER
Bio-Technology Co., Ltd. (Wuhan, China). Iscove’s modiﬁed
Dulbecco’s medium (IMDM) was from GIBCO. Fetal bovine
serum (FBS) and immunohistochemistry kit were from YHJM
(Beijing, China), and trypsin was from Biotech (Changchun,
China). 3-[4,5-Dimethylthiazol-2-yl]-2,5-diphenyltetrazolium
bromide (MTT) was from Sigma Chemicals (St. Louis,
USA). A reactive oxygen species assay kit was obtained from
Biotech (Biyuntian, China), and OHd was purchased from
Biological Engineering Company (Shanghai, China). All
chemicals used in the present study were of analytical grade.2.2. Cell culture
MyoFbs of 1–3 days old Wistar rats were obtained by
digestion with 0.05% trypsin of cardiac tissues at 37 1C for
5 min. The supernatants were collected and centrifuged at
1200 rpm for 10 min, with supernatant discarded. The cell
pellet was resuspended in IMDM containing 10% FBS and
plated in a culture ﬂask and incubated for at least 90 min at
37 1C in a 5% CO2 incubator. MyoFbs adhered to the culture
ﬂask surface while the cardiocytes remained unattached and
were discarded in the supernatant. MyoFbs with IMDM
containing 10% FBS were cultured for 48 h at 37 1C in a 5%
CO2 incubator, and then myoFbs were digested with 0.25%
trypsin. When ﬁbroblasts were covering the culture ﬂask surface,
the cells were diluted to 1.0 105 cells/L and seeded in 24 and 96-
well plates for immunocytochemistry andMTT assay, or diluted to
1.0 108 cells/L and plated in 100-mL glass ﬂasks for Western blot
assay. All cells were cultured at 37 1C in a humidiﬁed atmosphere
containing 5% CO2 and the medium was changed after 48 h.
2.3. Treatment protocols
MyoFbs were cultured for 48 h, and then these cells were
subjected to drug treatment for 24 or 48 h. Cells were serum-
starved for 12 h before drug treatment (myoFbs will tend to
synchronization before they are treated, due to myoFbs having
higher ability to divide). MyoFbs were assigned to 5 groups as
follows. Group A (control): cardiac ﬁbroblasts were cultured in
1% FBS for 24 h/48 h; group B (AngII: 106 M): cardiac
ﬁbroblasts were subjected to AngII (106 M) and 1% FBS
for 24 h/48 h; group C (AngII: 107 M): cardiac ﬁbroblasts
were subjected to AngII (107 M) and 1% FBS for 24 h/48 h;
group D (AngII: 108 M): cardiac ﬁbroblasts were subjected to
AngII (108 M) and 1% FBS for 24 h/48 h; group E (NAC,
AngII): cardiac ﬁbroblasts were subjected to a mixture of NAC
(104 M), AngII (107 M) and 1% FBS for 24 h/48 h.
2.4. Cell growth and proliferation assay
The growth and proliferation of myoFbs was determined by
the MTT assay. Cells (1 105 cells/mL) were seeded into 96-
well plates and cultured in IMDM with 10% FBS for 36 h.
They were exposed to various treatments for 12, 24 and 36 h.
After treatment, 10 mL of MTT solution (5 mg/mL in PBS)
was added in each well, and the cells were incubated for
another 4 h at 37 1C. The medium then was discarded and
150 mL dimethyl sulfoxide (DMSO) was added to each well for
the dissolution of formazan crystals. The absorbance of each well
was read at 490 nm with a Microplate Reader. The cell prolifera-
tion rate was expressed as a percentage of the control rate.
2.5. The contents of OHd
MyoFbs were washed three times with cold PBS after treat-
ment with NAC and AngII for 24 h, and then were diluted
with PBS to a cell concentration of about 108 cells/mL. By
repeated freezing and thawing so that myoFbs were lysed and
released intracellular OHd. MyoFbs were centrifuged at 2000–
3000 rpm for 20 min and the supernatant was collected to
measure the content of OHd by a hydroxyl radical ELISA kit
in accordance with instructions for operation.
Table 1 Effect of AngII and NAC on the proliferation of
myoFbs (mean7SD).
Group Proliferation rate of myoFbs (OD value)
Liying Wang et al.342.6. Immunohistochemistry and immunoﬂuorescein staining
MyoFbs were treated with NAC and AngII for 24 h, washed
three times with PBS at 37 1C for 5 min, ﬁxed with 4%
paraformaldehyde for 30 min, and then washed three times
with distilled water for 5 min each. Cells were lysed with 0.3%
Triton-X 100 for 15 min. MyoFbs were incubated with 1%
bovine serum albumin (BSA) for 30 min and then washed
three times with distilled water for 5 min each. A mixture of
anti-phosphate protein kinase C at 1:100 was added at 300 mL
per pore to incubate at 4 1C overnight. After three washes with
PBS for 5 min each, the goat anti-rabbit secondary antibodies
labeled with FITC were diluted with PBS at 1:50 and added to
the plates and incubated at 37 1C for 30 min. The cells were
then further incubated with 300 mL of propidium iodide (PI)
before being washed with PBS for 5 min and were immediately
analyzed under a laser confocal scanning microscope.
The membrane of myoFb stained green was measured via
the Image-pro plus V5.0. The mean density was measured
from 6 cells and determined by computer morphometry with
the Image-pro plus software.
2.7. Western blot analysis
MyoFbs were washed three times with cold PBS after treat-
ment for 48 h and then lysed at 4 1C in ice-cold immunopre-
cipitation lysis buffer containing All-in-One (phosphatase
inhibitor mixtures, Beyotime Biotechnology) and PMSF (ﬁnal
concentration at 10 mM) for 30 min. Cell lysates were cen-
trifuged at 12,000 g for 10 min and protein concentrations in
the supernatants were quantiﬁed with Coomassie brilliant
blue. Protein samples (20 mg) were separated by 12% denatur-
ing SDS-polyacrylamide gel electrophoresis and blotted onto a
nitrocellulose membrane. After electrophoresis, the proteins
were transferred to a nitrocellulose membrane by electro-
phoretic transfer. The membranes were blocked in 5% BSA in
PBS for 2 h, washed three times with 0.05% Tween-20 (PBS-
T) for 10 min each, and then incubated with primary antibody
(anti-p-PKCa antibodies at a dilution of 1:200 in PBS, anti-
tubulin at 1:5000 dilution) at 4 1C overnight. Having been
washed three times with PBS-Tween-20 for 10 min each, the
membranes were incubated for 2 h in diluted secondary anti-
body (horseradish peroxidase-conjugated goat anti-rabbit
antibodies, 1:1000 dilution) for 2 h. After washing three times
with PBS-T for 10 min each, the bands were detected by DAB,
then analyzed on a Tanon GIS gel image processing system.
2.8. Statistical analysis
Data were expressed as mean7SD. The mean values were
compared using Student’s t-test. P values less than 0.05 were
considered signiﬁcant.12 h 24 h 36 h
A 0.29570.12 0.32570.15 0.31670.83
B 0.37470.13 0.39870.1a 0.38770.11
C 0.38970.17 0.48370.12a 0.41270.14
D 0.34170.14 0.37770.13a 0.36270.15
E 0.34170.14 0.35770.13 0.33970.11
aPo0.01 vs. control group.3. Results
3.1. Promotion by AngII and inhibition by NAC of the growth
and proliferation of myoFbs
To investigate whether the effect of AngII on proliferation is
related to time and concentration, different concentrationsand times of exposure of AngII were examined. In Table 1,
after treatment with AngII (108 to 106 M) and NAC
(104 M) for different times (12, 24 and 36 h), proliferation
of myoFbs was measured by MTT. In the AngII (107 M
and 24 h) group, cell proliferation of myoFbs was
0.48370.12. Concentration (107 M) and time (24 h) of
AngII affected the proliferation of myoFbs, compared with
control group (Po0.01). MyoFbs proliferation was not
evident at AngII (108 and 106 M) for 12 h or 36 h,
compared with control group; the NAC (104 M) group
proliferation rate was 0.35770.13 (24 h). The above data
show that the proliferative effect of AngII depended on
concentration and time.
3.2. Effect of NAC on OHd content of myoFbs
After the treatment of myoFbs with NAC and AngII for 24 h,
the content of OHd of myoFb was signiﬁcantly increased in
AngII group (93.5371.78) compared with that in control
group (80.2571.15) (Po0.01), whereas the quantity of OHd
was decreased in antioxidant NAC group (76.5771.38)
(Table 2). OHd of myoFbs produced by AngII induction
was inhibited by NAC.
3.3. Effect of NAC on content of ROS in myoFbs
A ﬂuorescence assay was used to detect the expression of
ROS. Fig. 1 shows the average ﬂuorescence density of myoFbs
measured by computer morphometry. After the treatment
with NAC, the values of the mean density decreased. ROS
generation of myoFbs induced by AngII was signiﬁcantly
higher than that in control group (Po0.01), while the content
of ROS in myoFbs in the NAC intervention group was less
than AngII group (Po0.05). NAC may inhibit the formation
of ROS in myoFbs, and thus to some extent to inhibit the
proliferation of myoFbs.
3.4. Translocation and expression of p-PKCa in membrane
After myoFbs were treated with AngII (107 M) for 48 h, the
expression of p-PKCa increased markedly (Po0.01 vs. con-
trol). In Fig. 2A, light yellow represents the nucleus and
brown granules indicated p-PKCa. Brown particles were more
evident in the AngII group, while less apparent in the control
group. After treatment with NAC, brown particles clearly
decreased compared with those in AngII group (Po0.05).
Table 2 Inhibitory effect of NAC on the content of OHd
in myoFbs treated with AngII.
Group Content of OHd in myoFbs (U/mL)
12 h 24 h 36 h
A 78.4571.23 80.2571.15 79.8071.83
C 89.4071.37a 93.5371.78a 90.0771.16
E 79.3172.71 76.5771.38 73.9271.08
aPo0.01 vs. control group.
Figure 1 NAC effect on ROS generation of myoFbs with laser
confocal scanning microscopy (400 ). (a) Control group,
(b) AngII (107 M), and (c) NAC (104 M). Green density of
myoFbs was measured by computer morphometry using the
Image-Pro Plus software. Values represent as mean7SD (n¼6–8/
group). nnPo0.01 vs. control group; ]Po0.05 vs. AngII group.
Figure 2 Translocation and expression of p-PKCa with immu-
nohistochemistry (200 ). (a) Control group, (b) AngII (107 M),
and (c) NAC (104 M). Brown density of myoFbs was measured
by computer morphometry using the Image-Pro Plus software.-
Values represent as mean7SD (n¼6–8/group). nnPo0.01 vs.
control group; ]Po0.05 vs. AngII group.
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confocal scanning microscopy. In Fig. 3A, the red color stands
for nucleus and green particles were p-PKCa. In the AngII
group, green particles were increased while they were
decreased in the control group. After treatment with NAC,
green particles decreased compared with those in AngII group.
Figs. 2B and 3B show the average density of myoFbs as
measured by computer morphometry. After the treatment
with NAC, the mean density decreased. NAC could therefore
decrease the expression of p-PKCa.
Figure 3 Translocation and expression of p-PKCa with laser
confocal scanning microscope (400 ). (a) Control group, (b) AngII
(107 M), and (c) NAC (104 M). Brown density of myoFbs was
measured by computer morphometry using the Image-Pro Plus soft-
ware. Values represent as mean7SEM (n¼6–8/group). nnPo0.01 vs.
control group; ]Po0.05 vs. AngII group.3.5. Phosphorylation of PKCa
In order to deﬁne the mechanisms of how AngII promotes
cardiac ﬁbrosis, PKCa phosphorylation was quantiﬁed by
Western blot analysis (Fig. 4A). It was found that the
phosphorylation was signiﬁcantly increased in the AngII
group compared with that in the control group (Po0.01).
Phosphorylation of PKCa was reduced in NAC treatment
group (Po0.05 vs. AngII group) (Fig. 4B).
Figure 4 Western blotting analysis of p-PKCa in myoFb are
shown. b-actin (bottom) was used as control. The lower panels are
summary data of p-PKCa expression in myoFbs in different
groups. (a) Control, (b) AngII (107 M), and (c) NAC (104 M).
Values were expressed as fold changes over the control and
presented as mean7SD, representative of three independent
experiments. nnPo0.01 vs. control group; ]Po0.05 vs. AngII
group.
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It is well documented that the abnormal proliferation of
myoFbs contributes to the pathogenesis of cardiac ﬁbrosis.
On the one hand, myoFbs participate in the process of cardiac
ﬁbrosis10,11, on the other hand, recent studies demonstrate
that the inhibition of phenotypic conversion of ﬁbroblasts to
myoFbs by cAMP could prevent the cardiac ﬁbrosis12,13,
suggesting a key role of myoFbs in ﬁbrosis. AngII promoted
myoFbs proliferation in this study. During pathological
conditions of the heart, an activated renin–angiotensin–aldos-
terone system (RAAS) induces the expression of TGFb1 that
in turn promotes the phenotypic conversion of ﬁbroblasts to
myoFbs14,15. AngII plays a critical role in the process of
cardiac ﬁbrosis16.
MyoFbs also play a crucial role in the development of
cardiac ﬁbrosis due to their over-proliferation. Therefore,
inhibiting the proliferation of myoFb is an important anti-
ﬁbrotic strategy. Recent research has shown that over-
proliferation of myoFb was associated with PKCa17. PKCa
is expressed ubiquitously among cells and tissues18–20. Several
lines of evidence indicate that PKCa plays a critical role in
cellular functions such as the control of growth, differentiation
and apoptosis21,22. PKCa was one of the regulatory factors of
myocardial ﬁbrosis, and participated in the process of myo-
cardial remodeling17,23–25. PKCa is highest in cytoplasm in
normal conditions and translocates to the cell membrane when
it is phosphorylated in response to numerous factors24,25.
Many factors mediate the various cellular functions via PKC
signaling in cardiovascular function and disease26. PKC is a
group of closely related serine-threonine protein kinases, and
PKC isozymes are expressed in all tissues. Members of the
PKC family are important signal transducers in virtually everymammalian cell type. In the heart, PKC isozymes were
thought to participate in a signal network that programs
developmental and pathological myoFbs proliferation. PKC
isozymes are involved in a variety of chronic cardiac dis-
eases27,28 as well as in acute cardiac injuries and precondition-
ing cytoprotection25. Interference with such signaling
pathways may result in inhibition of myoFbs proliferation,
myocardial ﬁbrosis and reverse cardiac remodeling. To inves-
tigate whether AngII induced cardiac ﬁbrosis through PKCa
signal transduction pathways, the expression of p-PKCa and
its translocation was measured with immunohistochemistry
and a laser confocal scanning microscopic imaging. The results
demonstrate that AngII promoted myocardial ﬁbrosis by
activation of PKCa. Under normal conditions, PKCa locates
in cytoplasm without activation. PKCa will translocate to
membrane when it is activated by AngII to myoFb, and form
p-PKCa.
A recent study29–31 showed that reactive oxygen species
(ROS) are involved in cell proliferation, differentiation and
apoptosis as messenger molecules and participate in the
AngII-induced myocardial hypertrophy process. ROS results
from aerobic metabolism, generating superoxide anion (O2
d),
the hydroxyl radical (OHd), hydrogen peroxide (H2O2), singlet
oxygen (1O2), lipid peroxide intermediate alkoxyl radicals
(LOd), and alkyl peroxy radicals (LOOd). Recent research
reported that the hydroxyl radical (OHd) could promote
ECV304 cell proliferation29. ROS are unstable and highly
reactive32 and may serve as a ‘‘split signal’’ second messen-
ger33, through activation of protein kinase C triggering a series
of protein phosphorylation cascade of signal transduction34
that may be necessary to regulate cell proliferation and
ultimately determine the fate of cells35,36.
NAC is a glutathione precursor which has a strong anti-
oxidant capacity37. Treatment with NAC inhibited the pro-
liferation of myoFbs induced by AngII (Po0.05). To
investigate whether the proliferative effects of AngII are
related to ROS, NAC was used to reduce the effects of ROS
in this study. From above data, we know that proliferation of
myoFbs induced by AngII is inhibited by NAC, suggesting
that ROS take part in the AngII-promoted proliferation of
myoFbs.5. Conclusions
AngII could promote the proliferation of myoFbs and resulted
in myocardial ﬁbrosis in vitro. Our study clearly demonstrates
that ROS and p-PKCa are involved in the process of
myocardial ﬁbrosis induced by AngII. NAC could inhibit
the proliferation of myoFbs by decreasing the content of OHd
and inhibiting translocation and expression of PKCa. Above
all, we found that the proliferation of myoFbs was induced by
AngII by way of the ROS–PKCa signal transduction path-
ways. The current results provide a possible therapeutic target
for myocardial ﬁbrosis and to reverse myocardial remodeling
induced by AngII through ROS and PKCa signal transduction
pathways.
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